Akums Drugs & Pharmaceuticals Ltd

Akums Drugs | 544222

Market Closed

₹683.35

+₹25.14 (+3.82%)

As on 10/07/26, 12:17 PM

Market Cap10,359.67 CR

Current Price₹683.35

High / Low₹676 / 409.3

PE Ratio27.96

Book Value₹216.41

Dividend Yield0.63%

ROCE12.53%

ROE4.72%

Face Value₹2.00

Current Vol.3,42,358

Average Vol.---

ISININE09XN01023

PB Ratio2.15

Debt to Equity0.04

Net Profit Margin5.88

Operating Margin14.47

Share Price Chart - Akums Drugs & Pharmaceuticals Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹658.2₹659.1

₹683.35

Previous CloseToday's Open

₹409.3₹676

₹683.35

52W Low52W High

₹659.1Today's Open

₹658.2Previous Close

3,42,358Volume

₹409.352W Low

₹67652W High

Ratios

No data available

About Company

Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC
Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas
They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients
Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services
Their specialization extends to development and sale of APIs across diverse chemical processes and therapeutic areas such as anti-infective, respiratory and diabetes
In 2004, the Company established first plant for oral dosage commissioned at 19, 20, 21, Sector 6A, Haridwar, Uttarakhand
In 2007, it established dedicated manufacturing site for oral liquid dosage and sterile products both at Haridwar, Uttarakhand
It incorporated Maxcure Nutravedics Limited to venture into nutraceuticals in 2009
In 2010, it dedicated a facility for hormones ; dedicated a facility for cosmetics and dermatology at Haridwar, Uttarakhand
In 2010, it incorporated Akumentis Healthcare Limited to venture into branded formulations

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI71.57

SMA 20621.45

SMA 50571.50

SMA 100531.92

SMA 200487.92

SMA 10633.22

MACD_12_26_Days22.91

EMA10Day635.06

EMA20Day617.57

EMA50Day580.29

MACD_12_26_9_Days1.27

EMA100Day545.33

EMA200Day527.11

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth5.85%

ROE8.06%

EBITDA Margin14.47%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	4,359.02	4,118.16	4,178.18	3,654.82	3,671.89
Interest	94.07	34.60	50.61	46.25	16.66
Expenses	3,836.99	3,653.68	4,055.20	3,361.04	3,763.61
Financing Profit	650.75	516.60	157.01	383.85	-68.89
Financing Margin %	15%	13%	4%	11%	-2%
Other Income	128.73	52.12	34.03	90.07	22.83
Depreciation	154.55	153.45	125.64	112.81	94.68
Profit before tax	382.10	345.25	-45.28	150.30	-193.20
Tax %	33%	0%	102%	35%	-30%
Net Profit	256.40	343.78	0.79	97.82	-250.87
EPS in Rs	16.67	22.60	-0.28	6.63	-17.65

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
ICICI PRUDENTIAL MUTUAL FUND	22 Dec ‘25	Purchase	72,78,535	₹428	2335.47%
RUBY QC INVESTMENT HOLDINGS PTE.LTD.	22 Dec ‘25	Sell	72,78,535	₹428	2335.47%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

10 Jul 2026

AGM

14 May 2026

03 Jul 2026

Final Dividend (₹1)

Recommendation of Final cum Special Dividend Recommended a Final Dividend of Rs. 1.00/- per equity share and a special dividend of Rs. 2.00/- per equity share for the Financial Year ended March 31, 2026 and fixation of record date. The Board of Directors have recommended a final dividend of Rs. 1.00/- (@ 50%) per equity share and a special dividend of Rs. 2.00/- (@ 100%) per equity share having face value of Rs. 2/- (Rupees Two) each fully paid-up for the Financial Year ended March 31, 2026, subject to the approval of the Shareholders of the Company at the ensuing Annual General Meeting

14 May 2026

03 Jul 2026

Special Dividend (₹2)

14 May 2026

18 Jul 2025

AGM

26 May 2025

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
658	10,357	39	3	24	0	5.88%
1,939	4,65,195	37	6	30	0	19.78%
6,811	1,80,823	69	11	59	0	23.41%
4,897	1,65,725	76	20	50	1	11.09%
1,442	1,16,467	31	3	23	0	9.92%
1,160	1,15,695	21	4	17	0	19.86%
2,503	1,14,441	20	5	16	0	14.56%
1,270	1,05,987	26	3	17	0	12.34%
2,531	1,04,544	52	6	36	0	14.39%
1,587	92,144	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Frequently Asked Questions

What is Share Price of Akums Drugs & Pharmaceuticals Ltd?

The current share price of Akums Drugs & Pharmaceuticals Ltd (Akums Drugs) is ₹683.35. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Akums Drugs & Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of Akums Drugs & Pharmaceuticals Ltd is 683.35. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Akums Drugs & Pharmaceuticals Ltd?

Akums Drugs & Pharmaceuticals Ltd has a 52-week high of ₹676.00 and a 52-week low of ₹409.30. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Akums Drugs & Pharmaceuticals Ltd?

Akums Drugs & Pharmaceuticals Ltd offers a dividend yield of 0.44%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Akums Drugs & Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of Akums Drugs & Pharmaceuticals Ltd is ₹17.07. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Akums Drugs & Pharmaceuticals Ltd?

Akums Drugs & Pharmaceuticals Ltd has a Return on Equity (ROE) of 4.72%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video